Clinical Trial Update: Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating dexamethasone for improving clinical outcomes in patients undergoing coronary artery bypass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Indonesia University | Conditions: Coronary Artery Disease, Inflammatory Response | Phase 4 | Status: COMPLETED